Skip to search formSkip to main contentSkip to account menu

tasimelteon

Known as: N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide, N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide, tasimeltéon 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Ta Simeiqiong intermediates and preparation method thereof, the present invention obtain compound I with benzyl bromine reaction… 
2014
2014
The melatonin receptor agonist tasimelteon has been approved to treat non-24 sleep–wake disorder in totally blind individuals… 
Review
2014
Review
2014
Melatonin agonists have become an area of interest in the treatment of sleep disorders. This article reviews the available data… 
2014
2014
Free-running type or non 24 hour sleep wake disorder is a rare but chronic circadian rhythm sleep disorder (CRSD) that disrupts… 
2014
2014
NEW DRUG APPROVALS Hetlioz for Non-24-Hour Sleep-Wake Disorder The FDA has approved tasimelteon (Hetlioz, Vanda Pharmaceuticals… 
2013
2013
Dolutegravir Tablets (Tivicay) Manufacturer: GlaxoSmithKline/Viiv, Research Triangle Park, N.C. Indication: Dolutegravir is… 
2010
2010
Normal circadian rhythms are synchronized to a regular 24 hr environmental light/dark cycle. Both the su- prachiasmatic nucleus… 
Review
2010
Review
2010
There has been a search for more effective and safe hypnotic drugs in the last decades. Zolpidem, zaleplon, zopiclone… 
2009
2009
Slaapstoornissen als gevolg van verstoring van het circadiane ritme komen veel voor, onder andere bij mensen die ’s nachts werken…